Josh Gottheimer · ITCI
Josh Gottheimer's ITCI trades
- Transactions
- 3
- Buys / sells
- 0 / 3
- Disclosed range
- $3K – $45K
- Last filed
- 2025-05-14
ITCI transactions reported by Josh Gottheimer
| Type | Owner | ||||
|---|---|---|---|---|---|
Intra-Cellular Therapies Inc. ITCI | Sale | Joint | $1,001 - $15,000 | 2025-05-14 #20030338 | |
Intra-Cellular Therapies Inc. ITCI | Sale | Joint | $1,001 - $15,000 | 2025-04-10 #20029083 | |
Intra-Cellular Therapies Inc. ITCI | Sale | Joint | $1,001 - $15,000 | 2025-02-10 #20026732 |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
The tracker is free
A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.
More tickers reported by Josh Gottheimer
Josh Gottheimer and ITCI — questions
Did Josh Gottheimer buy or sell ITCI?
House Clerk filings for 2025 and 2026 show 0 purchases and 3 sales of Intra-Cellular Therapies Inc. (ITCI) reported by Josh Gottheimer, between 2025-01-24 and 2025-04-03. Reported owner: Joint.
How much ITCI did Josh Gottheimer trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $3K – $45K across 3 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last ITCI filing by Josh Gottheimer?
The most recent periodic transaction report containing a ITCI row was filed on 2025-05-14. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with Intra-Cellular Therapies Inc.. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
Josh Gottheimer ITCI disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included